The Perfect Storm, page-38

Hi Osi - thanks for the info in your post above - it is good to see some figures put down actually looking at how revenues may look into the future.

I have been keeping half an eye on CDY over the last year or so as the diagnostics industry is an area of interest for me with ADO.

The issue of the .002 options were an obvious save for long term holders but it does cause a big dilution to what ever profits may exist in the future.

I think it is great if these small bios can get through to commercialisation and provide a great return for the investors that helped fund them to that point especially when these companies can have a great impact on improved diagnosis and healthcare.

One thing I do see here is an obvious interest in promotion and speculation of the company with a clear focus on an appreciating price in the options.

Ask yourself if these people would be posting here if the options were not on market?